What is the appropriate treatment for uncomplicated cellulitis using Keflex (cephalexin) and doxycycline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Uncomplicated Cellulitis with Cephalexin and Doxycycline

For uncomplicated cellulitis, cephalexin 500 mg orally 3-4 times daily for 5 days is the recommended first-line treatment, with doxycycline being an alternative option when MRSA coverage is needed. 1

First-Line Treatment for Uncomplicated Cellulitis

Cephalexin (Keflex)

  • Dosage: 500 mg orally 3-4 times daily
  • Duration: 5-6 days 1
  • Target organisms: Primarily effective against Streptococcus pyogenes and methicillin-susceptible Staphylococcus aureus (MSSA) 2
  • Indication: FDA-approved for skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes 2

When to Consider Doxycycline

Doxycycline should be considered when MRSA coverage is needed, particularly in patients with:

  • Prior MRSA infection
  • Recent hospitalization
  • Antibiotic use in the past 3 months
  • Close contact with MRSA-infected individuals
  • Penetrating trauma
  • Evidence of MRSA infection elsewhere
  • MRSA nasal colonization
  • Injection drug use
  • Systemic inflammatory response syndrome (SIRS) 1

Evidence Supporting Treatment Recommendations

Treatment Duration

  • 5 days of antibiotic therapy is sufficient for uncomplicated cellulitis 1, 3
  • A randomized controlled trial showed no significant difference in clinical outcomes between 5 days and 10 days of therapy (98% success rate in both groups) 3
  • Treatment should be extended if the infection has not improved within 5 days 1

MRSA Coverage

  • For nonpurulent cellulitis (without abscess or purulent drainage), beta-hemolytic streptococci are the predominant pathogens, and MRSA coverage is generally not necessary 4, 5
  • A randomized controlled trial found that adding trimethoprim-sulfamethoxazole (TMP-SMX) to cephalexin did not significantly improve outcomes for uncomplicated cellulitis in the per-protocol analysis 6
  • However, in areas with high MRSA prevalence, antibiotics with MRSA activity showed higher success rates compared to cephalexin alone 7

Treatment Algorithm for Uncomplicated Cellulitis

  1. Initial Assessment:

    • Determine if the cellulitis is purulent (with abscess or drainage) or nonpurulent
    • Assess for MRSA risk factors
    • Check for signs of systemic illness or severe infection
  2. For Nonpurulent Cellulitis without MRSA Risk Factors:

    • First choice: Cephalexin 500 mg orally 3-4 times daily for 5 days 1
  3. For Nonpurulent Cellulitis with MRSA Risk Factors:

    • Consider doxycycline as an alternative
    • Or use cephalexin plus an MRSA-active agent if severe or extensive
  4. For Purulent Cellulitis:

    • MRSA coverage is recommended (doxycycline would be appropriate)
  5. Follow-up Assessment:

    • Evaluate response after 48-72 hours
    • If not improving, consider:
      • Extending treatment duration
      • Changing antibiotics based on likely pathogens and local resistance patterns
      • Assessing for complications or underlying conditions

Common Pitfalls and Caveats

  • Inadequate treatment duration: While 5 days is typically sufficient, treatment should be extended if the infection has not improved 1
  • Failure to address predisposing factors: Treat underlying conditions that may contribute to cellulitis 1
  • Inappropriate MRSA coverage: Routine MRSA coverage is not necessary for all cases of nonpurulent cellulitis 4, 5
  • Missing signs of deeper infection: Patients with SIRS, altered mental status, hemodynamic instability, or signs of deeper infection should be admitted for IV antibiotics 1
  • Cross-reactivity concerns: Patients with immediate (anaphylactic-type) hypersensitivity to penicillin may have up to 10% cross-reactivity with cephalexin 1

Adjunctive Measures

  • Elevation of the affected area to reduce edema
  • Treatment of predisposing factors (edema, underlying skin disorders)
  • Careful examination and treatment of interdigital toe spaces
  • Maintaining good personal hygiene 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.